0001628280-23-025009.txt : 20230717
0001628280-23-025009.hdr.sgml : 20230717
20230717172021
ACCESSION NUMBER: 0001628280-23-025009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230713
FILED AS OF DATE: 20230717
DATE AS OF CHANGE: 20230717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patience David
CENTRAL INDEX KEY: 0001970009
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31822
FILM NUMBER: 231092381
MAIL ADDRESS:
STREET 1: C/O ACCELERATE DIAGNOSTICS, INC.
STREET 2: 3950 S. COUNTRY CLUB ROAD, SUITE 240
CITY: TUCSON
STATE: AZ
ZIP: 85714
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Accelerate Diagnostics, Inc
CENTRAL INDEX KEY: 0000727207
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 841072256
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3950 S. COUNTRY CLUB ROAD #470
STREET 2: BUILDING 3-307
CITY: TUCSON
STATE: AZ
ZIP: 85714
BUSINESS PHONE: 303-863-8088
MAIL ADDRESS:
STREET 1: 3950 S. COUNTRY CLUB ROAD #470
STREET 2: BUILDING 3-307
CITY: TUCSON
STATE: AZ
ZIP: 85714
FORMER COMPANY:
FORMER CONFORMED NAME: ACCELR8 TECHNOLOGY CORP
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: HYDRO SEEK INC
DATE OF NAME CHANGE: 19880802
4
1
wk-form4_1689628810.xml
FORM 4
X0508
4
2023-07-13
0
0000727207
Accelerate Diagnostics, Inc
AXDX
0001970009
Patience David
C/O ACCELERATE DIAGNOSTICS, INC.
3950 S. COUNTRY CLUB ROAD, SUITE 470
TUCSON
AZ
85714
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-07-13
4
M
0
330
0
A
7849
D
Common Stock
2023-07-13
4
S
0
92
6.90
D
7757
D
Common Stock
760
I
By Spouse IRA
Employee Restricted Stock Units
2023-07-13
4
M
0
330
0
D
Common Stock
330
1655
D
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding
obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
On July 11, 2023, the issuer effected a reverse stock split of its common stock at a ratio of 1-for-10 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, proportionate adjustments were made to the number of
shares of the issuer's common stock underlying its outstanding equity awards, warrants and convertible notes, as well as the exercise or conversion price, as applicable. The amounts reported herein (and to be reported in
subsequent reports) have been adjusted to reflect the Reverse Stock Split.
/s/ David Patience
2023-07-17